Bert Houben

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Top Venues

The EMBO journal

Science advances

Nature communications

Biomacromolecules

This page only lists publications with an associated author ORCID identifier.

Publications

Ramon Duran-Romaña, Bert Houben, Matthias De Vleeschouwer, Nikolaos N Louros, Matthew P Wilson, Gert Matthijs, Joost Schymkowitz, Frederic Rousseau
N-glycosylation as a eukaryotic protective mechanism against protein aggregation. Science advances 10 (5) (2024)
Ramon Duran-Romaña, Bert Houben, Matthias De Vleeschouwer, Nikolaos N Louros, Matthew P Wilson, Gert Matthijs, Joost Schymkowitz, Frederic Rousseau
N-glycosylation as a eukaryotic protective mechanism against protein aggregation. Science advances 10 (5) (2024)
Ramon Duran-Romaña, Bert Houben, Matthias De Vleeschouwer, Nikolaos N Louros, Matthew P Wilson, Gert Matthijs, Joost Schymkowitz, Frederic Rousseau
N-glycosylation as a eukaryotic protective mechanism against protein aggregation. Science advances 10 (5) (2024)
Emiel Michiels, Kenny Roose, Rodrigo U Gallardo, Ladan Khodaparast, Laleh Khodaparast, Rob van der Kant, Maxime Siemons, Bert Houben, Meine Ramakers, Hannah Wilkinson, Patricia Guerreiro, Nikolaos Louros, Suzanne J F Kaptein, Lorena Itatí Ibañez, Anouk Smet, Pieter Baatsen, Shu Liu, Ina Maja Vorberg, Guy Bormans, Johan Neyts, Xavier Saelens, Frederic Rousseau, Joost Schymkowitz
Author Correction: Reverse engineering synthetic antiviral amyloids. Nature communications 14 (1) (2023)
Joëlle A J Housmans, Bert Houben, Margarita Monge-Morera, Diego Asvestas, Hung Huy Nguyen, Grigoria Tsaka, Nikolaos Louros, Sebastien Carpentier, Jan A Delcour, Frederic Rousseau, Joost Schymkowitz
Investigating the Sequence Determinants of the Curling of Amyloid Fibrils Using Ovalbumin as a Case Study. Biomacromolecules 23 (9) (2022)
Katerina Konstantoulea, Patricia Guerreiro, Meine Ramakers, Nikolaos Louros, Liam D Aubrey, Bert Houben, Emiel Michiels, Matthias De Vleeschouwer, Yulia Lampi, Luís F Ribeiro, Joris de Wit, Wei-Feng Xue, Joost Schymkowitz, Frederic Rousseau
Heterotypic Amyloid β interactions facilitate amyloid assembly and modify amyloid structure. The EMBO journal (2021)
Anita Pras, Bert Houben, Francesco Antonio Aprile, Renée Seinstra, Rodrigo Gallardo, Leen Janssen, Wytse Hogewerf, Christian Gallrein, Matthias De Vleeschouwer, Alejandro Mata-Cabana, Mandy Koopman, Esther Stroo, Minke de Vries, Samantha Louise Edwards, Janine Kirstein, Christopher M Dobson, Salvatore Fabio Falsone, Frederic Rousseau, Joost Schymkowitz, Ellen A A Nollen
The cellular modifier MOAG-4/SERF drives amyloid formation through charge complementation. The EMBO journal 40 (21) (2021)
Emiel Michiels, Kenny Roose, Rodrigo U Gallardo, Ladan Khodaparast, Laleh Khodaparast, Rob van der Kant, Maxime Siemons, Bert Houben, Meine Ramakers, Hannah Wilkinson, Patricia Guerreiro, Nikolaos Louros, Suzanne J F Kaptein, Lorena Itatí Ibañez, Anouk Smet, Pieter Baatsen, Shu Liu, Ina Maja Vorberg, Guy Bormans, Johan Neyts, Xavier Saelens, Frederic Rousseau, Joost Schymkowitz
Reverse engineering synthetic antiviral amyloids. Nature communications 11 (1) (2020)
Bert Houben, Emiel Michiels, Meine Ramakers, Katerina Konstantoulea, Nikolaos N Louros, Joffré Verniers, Rob van der Kant, Matthias De Vleeschouwer, Nuno Chicória, Thomas Vanpoucke, Rodrigo U Gallardo, Joost Schymkowitz, Frederic Rousseau
Autonomous aggregation suppression by acidic residues explains why chaperones favour basic residues. The EMBO journal 39 (11) (2020)